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a b s t r a c t
Gamma cyclodextrin (γ-CD) metal organic frameworks (CDMOFs) were synthesized by coordinating γCDs with potassium hydroxide (KOH), referred hereafter as CDMOF-a, and potassium benzoate
(C7H5KO2), denoted as CDMOF-b. The obtained CDMOF structures were characterized using nitrogen
sorption isotherm, thermo-gravimetric analysis (TGA), X-ray diffraction (XRD), and scanning electron
microscopy (SEM). High surface areas were achieved by the γ-CD based MOF structures where the
Langmuir speciﬁc surface areas (SSA) of CDMOF-a and CDMOF-b were determined as 1376 m2 g  1 and
607 m2 g  1; respectively. The dehydrated CDMOF structures demonstrated good thermal stability up to
250 °C as observed by the TGA studies. XRD results for CDMOF-a and CDMOF-b reveal a body centeredcubic (BCC) and trigonal crystal system; respectively. Due to its accessible porous structure and high
surface area, acetaldehyde was successfully encapsulated in CDMOF-b. During the release kinetic studies,
we observed peak release of 53 μg of acetaldehyde per g of CDMOF-b, which was 100 times greater than
previously reported encapsulation in β-CD. However, aldol condensation reaction occurred during encapsulation of acetaldehyde into CDMOF-a. This research work demonstrates the potential to encapsulate
volatile organic compounds in CDMOF-b, and their associated release for applications including food,
pharmaceuticals and packaging.

1. Introduction
Cyclodextrins (CDs) are naturally synthesized from starch using
glycosyltransferase enzymes. These cyclic structures exist in various forms including alpha (α), beta (β), gamma (γ) and delta (δ)
form [1]. The difference among these forms is attributed to the
numbers of 1,4-linked glucopyranose units which are attached in a
cyclic arrangement. The α, β, γ, and δ forms have 6, 7, 8, and
9 glucopyranose units; respectively. As a result, the molecular
weight of CDs varies from 972 to 1459 g mol  1 while their cavity
diameter ranges between 0.47 and 0.83 nm; respectively [2]. One
of the most remarkable properties of CDs is their ability to form
inclusion complexes (ICs) with volatile organic compounds due to
their hydrophilic exterior and hydrophobic interior. In such complexes, the volatile compounds are entrapped inside the hydrophobic CD pores due to secondary interactions. Such ICs have been
widely explored because of their potential applications in
n
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pharmaceutical [3], chemical [4], food and packaging industries
[5–7].
Several researchers have studied CD based ICs. The ability of
CDs to host a guest molecule depends on various factors such as
the size of the guest molecule, the pore size of the CDs, chemical
interactions between functional groups of the guest molecule and
hydrophobic pore interior. Veiga et al. [8] prepared tolbutamide
urea (TBM) β-CD complexes using kneading, freeze-drying and coprecipitation. The study concluded increased solubility, dissolution
and oral bioavailability of TBM due to the ICs. Almenar et al. [9]
studied post-harvest fungal decay inhibition efﬁcacy of acetaldehyde released from α, β or γ-CD acetaldehyde ICs. Effective
fungal decay was observed when β-CD acetaldehyde IC was employed during the marketable period. In another study, Almenar
et al. [10] also prepared hexanal and β-CD ICs in distilled water
with different concentrations. The authors encapsulated a maximum of 1.40 ppb hexanal in β-CD, and reported that the released
hexanal was effective against the growth of fungi. Although β-CD
allows the encapsulation of organic compounds through ICs, the
total amount that can be absorbed and later released is still relatively low.
Metal-organic frameworks (MOFs) are a new class of

microporous coordination polymers, which consists of metal ions
and organic linkers [11]. MOFs are well known for their high surface area, gas sorption, gas separation, selectivity and chemical
sensing [12–15]. The structural properties of MOFs are unique
among other materials including organic, inorganic and hybrid
porous structures such as zeolite and activated carbon. These
distinctive properties can be accredited to the high porosity of
MOFs and their reticulate symmetrical structures, which allow
them to host guest molecules like H2, CO2, N2 and CH4 [16–18].
Recently, cyclic macromolecules such as CDs [19–22], crown
ethers [23], pillararenes [24] and cucurbiturils [25] with inherently
large cavities have been utilized as organic struts for synthesizing
MOFs. Such structures offer two porosity levels, the ﬁrst one exists
naturally in these cyclic macromolecules, and the second is created
as the result of the chemical coordination between these struts
and the metal ions. Gamma CD, a cyclic macromolecule, has been
recently coordinated with earth metal ions (e.g., K þ , Rb þ , Na þ ,
and Cs þ ) to obtain cyclodextrin based metal organic frameworks
(CDMOFs) [19]. Gassensmith et al. [20] utilized γ-CD and Rb þ ions
based MOF structure, also known as CDMOF-2, for sensing and
quantiﬁcation of CO2 using electrochemical impedance spectroscopy. They credited reversible chemisorption of CO2 to electrochemical sensing of CDMOF-2. Yoon et al. fabricated [21] metal/
MOF/metal hetero-structures based memristors using single
crystals of CDMOF-2 for storage of electrical information. The
ability of these hetero-structures to work as resistive random-access memory (RRAM) was ascribed to the porous structure of
MOFs, which allows transportation of ions when infused with
electrolytes. The release of drug encapsulation in the γ-CD and K þ
ion MOF structure, generally known as CDMOF-1, has been studied
for drug carrier applications using Monte Carlo simulations [22]. In
their study, researchers observed strong interactions between the
metal centers of the MOF and the carbonyl group present in the
analgesic drug, ibuprofen [22].
In this study, we synthesized two different γ-CD-K þ ions based
MOFs using potassium hydroxide and potassium benzoate as
sources of K þ ion, referred hereafter as CDMOF-a and CDMOF-b;
respectively. Gamma-CDs were chosen as linkers due to their biobased nature as well as their unique ability to form ICs. These
CDMOFs were synthesized because of the non-toxic nature of alkali metals, presence of polar groups, open metal sites and the
ability of various CDs to form ICs [26–28]. The main objectives of
this study were: a) to synthesize CDMOF-a and CDMOF-b; b) to
determine the physical and thermal characteristics of CDMOF-a
and CDMOF-b crystals; and c) to run a proof-of-concept of the
ability of CDMOFs to encapsulate and release a selected organic
compound, acetaldehyde, which is known for its anti-fungal activity [9]. To the best of the authors' knowledge, no study has focused on encapsulation and release kinetics of acetaldehyde in
CDMOFs.

2.2. Synthesis and activation of CDMOF
The CDMOFs were synthesized as per Smaldone et al. [26]. One
mmol (1.30 g) of γ-cyclodextrin and 8 mmol (0.45 g) of KOH were
dissolved in 20 mL of deionized water and labeled in this work as
CDMOF-a. On the other hand, 1.6 mmol (0.256 g) of C7H5KO2 and
0.2 mmol (0.26 g) of γ-CD were diluted in 5 mL of deionized water
to synthesize CDMOF-b. The solutions were stirred continuously
for 6 h at 500 rpm followed by slow vapor diffusion of methanol
over a period of 3 to 7 d. After the CDMOF crystals were produced
in the solution with an average yield of 1.25 g for the CD and KOH,
and 0.30 g for the CD and C7H5KO2, the crystals were washed with
methanol to remove unreacted potassium ions and then ﬁltered
(samples were labeled as as-synthesized). After synthesis, the
CDMOFs were activated in a vacuum oven at 23 °C for 10 h at 4 kPa
(30 mmHg). Then, the temperature was increased to 45 °C and
maintained for an additional 12 h under the same vacuum pressure 4 kPa (samples were labeled as activated).
2.3. Surface area and pore size
The gas sorption experiments were conducted using an iQMicropore-XR (Quantachrome Instruments, Boynton Beach, FL, USA).
The surface area, pore sizes and diameters of the CDMOFs were
calculated using the Brunauer-Emmett-Teller (BET) and Langmuir
methods. Samples weighing 0.05 g of each synthesized CDMOF-a
and CDMOF-b crystals were dehydrated for 10 h of vacuum pressure at 0.133 kPa (1 Torr) at 25± 0.1 °C followed by heating at 45 °C
for 12 h under the same pressure. The specimens were then
transferred to the sorption station where the N2 adsorption took
place at 77.3 K and N2 gas sorption at a relative pressure varying
from 10  5 to 0.99 [29].
2.4. Thermogravimetric analysis (TGA)
Thermal stability of CDMOF-a and CDMOF-b crystals were
evaluated using a TGA model 2950, from TA Instruments (New
Castle, DE, USA). A sample weight of 5 mg of activated CDMOF-a
and CDMOF-b were utilized to perform the studies. Samples were
heated from 25 to 450 °C at a rate of 10 °C min  1. Data were collected and analyzed using the Universal Analysis software version
2000 from TA Instruments.
2.5. X-ray diffraction (XRD)
The CDMOF-a and CDMOF-b activated crystals were examined
using a Bruker D8 advance X-ray diffractometer (Bruker AXS
GmbH, Karlsruhe, Germany) using Cu Kα (λ ¼0.154 nm) radiations
at 40 kV, 40 mA. The samples were studied using 1.2 mm primary
beam slit, and 2.0 mm detector slit over 3 to 40° 2 theta angles
with increments at 0.02° per min.

2. Methodology

2.6. Scanning electron microscopy (SEM)

2.1. Materials

To study the topography, activated CDMOF-a and CDMOF-b
crystals were sputter coated with approx. 8 nm thick platinum
coating. The coated specimens were examined using a JEOL JSM
6410 LV (JEOL Ltd., Tokyo, Japan) SEM, equipped with a tungsten
ﬁlament, at 10 kV accelerating voltage.

Gamma CD (purity 4 99%, food grade) was donated by Wacker
Chemical Corporation (Adrian, MI, USA). Potassium hydroxide
(KOH) pellets (ACS reagent, purity Z85%), and potassium benzoate (C7H5KO2) were purchased from Columbus Chemical Industries, Inc. (Phoenix, AZ, USA). Anhydrous methanol (purity
499.8%) and acetaldehyde (purity Z99%, FCC) were purchased
from Sigma-Aldrich Corp. (Saint Louis, MO, USA). Distilled and
deionized water was purchased from Avantor Performance Materials (Center Valley, PA, USA). All materials were used as received
unless otherwise indicated.

2.7. Encapsulation and release method
Acetaldehyde encapsulation was carried out after activating the
CDMOF-a and CDMOF-b. First, 1 g of activated CDMOF-a or
CDMOF-b was placed in a small aluminum pan that was placed in
a 2 L glass jar. Acetaldehyde (1 mL), previously stored in a

conventional refrigerator at 5 °C, was injected in the jar by airtight
micro-syringe at the same temperature and placed into a PTC-1
Temperature Cabinet at 25 70.1 °C with a controller device from
Sable System International, NA, USA. The glass jar was sealed with
a metal screw cap for 24 h in the chamber to insure the acetaldehyde penetration in the CDMOFs voids (samples were labeled
as encapsulated).
The release amount of acetaldehyde from the encapsulated
CDMOFs was determined by transferring the encapsulated
CDMOFs to a new 2 L glass jar. The acetaldehyde concentration in
the headspace was measured at 2570.1 °C. A gas chromatographer (GC), from Hewlett Packard GC 6890, CA, USA, with a
ﬂame ionization detector (FID) and a HP-5 column dimension
30 m  0.32 mm  0.25 μm, was used to determine the headspace
concentration of acetaldehyde release in the jar. An airtight gas
micro-syringe was used to extract 25 μL from the jar headspace
through a rubber septum placed in the metal screw lid and injected into the GC. Samples (25 μL) from the headspace were injected to the GC at 1, 2, 3, 4, 5, 6, and 24 h after the encapsulated
CDMOFs were introduced in the 2 L jar. The GC setting conditions
were as follows; oven temperature initially 80 °C for 2 min, and
increased to 200 °C at 10 °C min  1. The detector and the inlet
temperatures were at 240 °C. A calibration curve between 50 to
500 μL/L of acetaldehyde concentration was constructed at
257 0.1 °C with an adjusted R-square ¼0.990. Samples were tested in triplicate.
2.8. Color measurements
Encapsulated CDMOF-a and CDMOF-b specimens were examined using a Mold U-4100 HunterLab LabScan XE (Reston, VA,
USA) colorimeter for color changes after 24 h of activation and
after encapsulation. L* Lightness, a* from red positive to green
negative, b* from yellow positive to blue negative were obtained.
ΔE total color change was calculated using the equation
ΔE ¼[(ΔL*)2 þ (Δa*)2 þ (Δb*)2]1/2.
2.9. Data analysis
The entire data were analyzed using Tukey's HSD (Honestly
Signiﬁcant Differences) for the means comparisons with α ¼0.05
at 95% conﬁdence interval using SAS 9.4 Software (SAS Institute
Inc., Cary, NC, USA).

3. Results and discussion
3.1. Synthesis and activation of CDMOF
CDMOF-a and CDMOF-b were successfully produced with KOH
and C7H5KO2 respectively by using vapor diffusion crystallization
process at room temperature (23 °C). Methanol, a popular solvent
for crystal growth, was used because its high vapor pressure and
reasonably good solubility aids the crystal growth. CDMOF-b
crystals synthesized in 2–3 d whereas CDMOF-a crystal took approximately 1.3 d to crystallize from the solution, indicating the
slow nucleation rate in γ-CD- C7H5KO2 solution and CDMOF-b
crystal growth as compared to CDMOF-a, which may be affected
by various factors such as the basicity of the solution, source of the
metal ions, synthesis methodology and reactants concentration
[30,31]. Biemmi et al. [30] examined three different sources of Zn:
(i) Zinc (II) Nitrate (Zn(NO3)2  6H2O), (ii) Zinc acetate
(Zn(CH3COO)2  2H2O), and (iii) Zinc Oxide (ZnO), for the synthesis
of MOF-5. Although, MOF-5 synthesized using all the three Zn
sources mentioned above, the metal source signiﬁcantly impacted
both the morphology and crystal size. Smaller crystals were

Fig. 1. N2 sorption/desorption isotherms of CDMOF-a and CDMOF-b.

reported for Zinc acetate, the authors credited it to the faster nucleation due to higher basicity as compared to Zinc nitrate. Michida et al. [28] monitored the pH of the solution during the
CDMOF synthesis, and reported higher yield when the crystals are
grown from solution with higher basicity. We obtained 70% yield
for the synthesis of CDMOF-a crystals and 50% yield for CDMOF-b
crystals. The higher yield in case of CDMOF-a may be correlated to
higher basicity in the CDMOF-a solution.
3.2. Surface area and pore size
Porous materials are meticulously tailored to achieve speciﬁc
objectives. Physical characteristics such as surface area, pore size
and pore volume have signiﬁcant impact on the functionality, selectivity and intrinsic surface energy of these molecules. The
three-dimensional coordination arrangement between organic
linkers and ions signiﬁcantly inﬂuences the theoretical pore volume and the surface area. The N2 isotherms of CDMOF-a and
CDMOF-b samples are represented in Fig. 1. Type-1 isotherms, also
known as Langmuir isotherm, were observed for both the
CDMOFs, as per International Union of Pure and Applied Chemistry (IUPAC) classiﬁcation. The surface area, pore size and pore
volume of CDMOF-a and CDMOF-b are summarized in Table 1.
High adsorption at low partial pressure indicates microporous
nature of the material and correlates with high surface energy. As
observed from Table 1, CDMOF-a has more than two times the
surface area of CDMOF-b. This variation between the measured
surface areas may be attributed to the difference in the crystal
structure of the two MOFs and presence of the benzoate counteranions in the pores of CDMOF-b. CDMOF-a, K2(C48H80O40)(OH)2,
has body centered cubic crystal structure whereas CDMOF-b,

Table 1
Surface area (SA), pore size and pore volume of CDMOF-a and CDMOF-b.
Langmuir
Micropore
SA (m2 g  1) volume
(cm3 g  1)

CDMOFs

BET SA
(m2 g  1)

CDMOF-a
CDMOF-b

1229 7 6a 13767 18a
4177 110b 607 7 102b

Total pore
volume
(cm3 g  1)

Average
pore radius
(nm)

0.497 0.02a 0.50 7 0.02a 0.79 70.01a
0.187 0.03b 0.22 7 0.03b 0.40 70.40a

Note: Values in the same column with the same superscript letters are not signiﬁcantly different at α¼0.05. Micropore volumes were calculated at a radius of
2 nm, whereas total pore volumes were obtained at the relative pressure P/Po ¼ 0.99.

Fig. 2. (a) Location of the benzoate anion in the γ-CDMOF-b structure as stick representation of the crystal structure of CDMOF – benzoate anions are represented as spaceﬁlling mode, and (b) interactions between CD moiety and benzoate anion, reprinted with permission from Forgan et al. [32]. Copyright 2011 American Chemical Society.

K4(C96H160O80)(C7H5O2)2-(OH)2 has trigonal crystal structure
[26,32] .
The theoretical pore density of CDMOF-a has been calculated as
0.56 g cm  3 [26], which is close to the measured density
0.50 g cm  3. On another note, the micro-pore volume for
CDMOF-b was measured at  0.18 cm3 g  1, which can be attributed to the crystal structure and the fact that the pores are partly
occupied by the benzoate counter-anions [26,32]. This is also in
line with Forgan et al. [32] who reported the presence of stabilized
benzoate counter-anions in the γ-CD dimers due to formation of
two hydrogen bonds between γ-CD and benzoate anions. Fig. 2a
shows the location of benzoate counter-anions in the CDMOF-b
structure, and Fig. 2b represents the interactions between CD
moiety and benzoate anion.
3.3. Thermogravimetric analysis (TGA)
The thermograms of CDMOF-a and CDMOF-b are represented
in Fig. 3. The thermogravimetric studies indicate  8% weight loss
in CDMOF-a and CDMOF-b up to 150 °C. This weight loss can
primarily be associated with the loss of water molecules residing
in the pores of these MOF structures. CDMOF-b is thermally more
stable as compared to CDMOF-a. The sharp weight loss in CDMOFa around 264 °C can be ascribed to the destruction of hydroxyl
groups present in the γ-CD. On the other hand, in the case of
CDMOF-b the ﬁrst degradation peak was observed at approximately 315 °C. Further weight loss peaked around 428 °C due to

Fig. 3. Thermo-gravimetric analysis of CDMOF-a and CDMOF-b.

the decomposition of glucopyranose units, as observed by their
derivative proﬁles (DTGA). Relatively higher thermal stability of
the hydroxyl groups in CDMOF-b can be ascribed to the secondary
interaction with the benzoate counter-anions present in the
structure.

3.4. X-ray diffraction (XRD)
Diffraction patterns of CDMOF-a, K2(C48H80O40)(OH)2, CDMOFb are represented in Figs. 4a and b; respectively, matching previously reported XRD patterns [26]. The details of these crystals
have been previously reported [26,32] and freely accessible in the
database of The Cambridge Crystallographic Data Centre under the
CCDC numbers 773709 and 773711. K2(C48H80O40)(OH)2, crystals
have body centered cubic crystal, and they represent space group
I432 with axial lengths a ¼b¼c ¼31.006 Å and inter-axial angles
α ¼ β ¼ γ ¼90°. The formation of cubic crystal structure has been
ascribed to the eight-fold symmetry offered by γ-CD [29]. On the
other hand, CDMOF-b, K4(C96H160O80)(C7H5O2)2(OH)2, has trigonal
crystal system representing space group R32 with axial lengths
a¼ b¼42.6517 Å, c¼ 28.4636 Å and inter-axial angles α ¼ β ¼90°,
γ ¼120°.

Fig. 4. X-ray diffraction of activated CDMOF-a and CDMOF-b.

Fig. 5. (a) SEM image-I of CDMOF-a scale size 50 μm (b) SEM image-II of CDMOF-a scale size 50 μm (c) SEM image-I of CDMOF-b scale size 100 μm. (d) SEM image-II of
CDMOF-b scale size 200 μm.

3.5. Scanning electron microscopy (SEM)
External shape and size of the crystal are important for employing these crystals for various industrial applications [31]. In
addition, size variations can alter the physical properties of the
MOF particles. Morphology, size, shape and visible appearance of a
crystal are inﬂuenced by source of metal ion, solvent, impurities,
nucleation, crystal growth pattern and MOF crystal synthesis
parameters such as temperature and pressure [31–34]. SEM images of CDMOF-a and CDMOF-b are represented in Figs. 5a, b and c,
d; respectively. CDMOF-b has twice the size of CDMOF-a. The
larger size of CDMOF-b can be ascribed to lower nucleation rate
and slower crystal growth [30,34], which may have been inﬂuenced by the presence of benzoate counter-anions in the solution.
3.6. Encapsulation and release of acetaldehyde
Acetaldehyde, a naturally occurring antifungal, is a chemically
reactive compound. It is water-soluble and volatile in nature,
which poses retention and stability challenges. Cyclodextrin inclusion complexes have been utilized for retention and delivery of
controlled release of acetaldehyde [9]. Two level of pores exist in
the CDMOF which can potentially host acetaldehyde a. pore
(cavity), which exist naturally in the cyclic CD molecules with
diameter ranging from 7.5–8.3 Å and b. pores in the MOF structure
due to coordination of the CDs with the K þ ions. Both CDMOF-a
and CDMOF-b were evaluated as a proof of concept for the encapsulation of acetaldehyde. We successfully encapsulated acetaldehyde in CDMOF-b as supported by the release kinetics and
TGA studies. The successful encapsulation of acetaldehyde in the
γ-CDMOF-b can be ascribed to the strong quadrupole-quadrupole

interactions between acetaldehyde and electron rich aromatic ring
present in the benzoate counter-anion present in the MOF structure [31,35].
Wu et al. [35] studied adsorption mechanism of acetaldehyde
on MOF-5 using density functional theory. They observed strong
secondary interactions between aromatic rings present in the organic linkers and carbonyl group present in the acetaldehyde with
adsorption energy  10 kJ/mol. They also observed that any electron withdrawing groups attached to benzene ring increases the
acetaldehyde adsorption capacity of MOF-5.
The release of acetaldehyde from encapsulated CDMOF-b with
time can be observed in Fig. 6. The acetaldehyde release from 1 g
of CDMOF-b steadily increased and peaked to 53 μg/ after 5 h, the
release quantity dropped further with time. After 24 h, the concentration of acetaldehyde in the headspace dropped to around
30 μg acetaldehyde per 1 g of CDMOF. Almenar et al. [9] observed
similar trends in the acetaldehyde release kinetics study from βCD acetaldehyde ICs. However, the peak quantity of acetaldehyde
released from CDMOF-b is two order of magnitude higher than the
release reported in the β-CD ICs. It can be ascribed to high acetaldehyde sorption capacity of CDMOF-b as compared to β-CD due
to its high speciﬁc surface area and microporous structure of
CDMOF-b. We could not ﬁnd any study focused on encapsulation
and release of acetaldehyde in γ-CD. Fig. 6 also shows a large release variation of acetaldehyde at higher rates, which could be
attributed to preferential desorption of acetaldehyde and/or variation on efﬁciencies on the encapsulation method. Further assessment is required to streamline the release of acetaldehyde
from CDMOF-b. However, this information provides encouraging
results of a system that could create ICs with larger amount of the
organic compounds.

Fig. 8. Schematic representation of aldol condensation reaction.
Table 2
Color measurements of CDMOFs before and after exposure to acetaldehyde.

CDMOF-a
CDMOF-b
CDMOF-a encapsulated
CDMOF-b encapsulated

L*

a*

b*

ΔE

80.8 72.1a
72.4 7 2.6b
46.9 70.6c
48.27 0.8c

 0.05 7 0.1a
 0.5 7 0.1a
15.9 7 0.4b
 1.4 7 0.0c

 0.2 7 0.1a
 0.3 7 0.3a
39.4 7 0.6b
0.9 7 0.2c

80.8 7 2.1a
72.4 7 2.6b
63.3 7 0.4c
48.27 0.8d

Values in the same column with the same superscript letters are not signiﬁcantly
different at α ¼ 0.05.

Fig. 6. Release kinetics of acetaldehyde per gram of CDMOF-b.

resinous material. Researchers [36] have reported that aldehydes
can undergo self-condensation reaction producing reddish-brown
colored resinous material. In the case of CDMOF-b no chemical
reaction has occurred. However, carboxylate moieties present in
the benzoate anions bonded with hydroxyl groups present in the
CDMOF-b due to hydrogen bonding as shown in Fig. 2.
3.7. Color measurements

Fig. 7. Thermo-gravimetric analysis of as-synthesized, activated, and encapsulated
CDMOF-b.

To estimate the total amount of acetaldehyde encapsulated in
the CDMOF-b, we utilized TGA studies. Fig. 7 shows TGA thermographs of as-synthesized, activated and encapsulated CDMOFb. All the samples demonstrated good thermal stability below
250 °C. As synthesized samples lost  12–14% weight at 100 °C as
compared to its actual weight which can be ascribed to loss of
water present in the CDMOF-b pores. Activated samples lost
around 4% weight, this weight could be associated with adsorption
of moisture or other molecules during the handling of CDMOF-b
before TGA studies. Encapsulated samples lost  13.75 wt% at
150 °C, which could primarily be associated with the loss of the
acetaldehyde present in the CDMOF-b pores. The thermal degradation onset temperatures for as synthesized, activated and
encapsulated γ-CDMOF-b were observed between 250–300 °C.
Although CDMOF-a has higher surface area than CDMOF-b, we
struggled to encapsulate the acetaldehyde in CDMOF-a due to aldol self-condensation reaction, represented in Fig. 8, because of
the presence of hydroxide counterions in the pore of MOF which
may have released from the potassium hydroxide during the MOF
synthesis. Aldol condensation was also evident as color change in
the CDMOF-a crystals from white to brownish red in couple of
minutes during the encapsulation trials due to formation of

Encapsulated CDMOF-a and CDMOF-b and activated CDMOF-a
and CDMOF-b crystals were examined using the colorimeter to
capture and record the color changes due to aldol condensation
reaction that occurred during encapsulation of acetaldehyde in
CDMOF-a. Color parameters of CDMOF-a and CDMOF-b exposed to
acetaldehyde are represented in Table 2. The distinguishing color
change was recorded in the encapsulated CDMOF-a, where the
value of b* yellowness and redness were very high compared to
the negative values of the encapsulated CDMOF-b toward the blue
and green regions, respectively. In general, the brightness values of
the crystal decreased in the encapsulated samples, which is an
indication of the luminosity decreasing. The redness and yellowness in the reacted CDMOF-a again supports the formation of
reddish-brown colored resinous material due to the aldol condensation reaction of acetaldehyde. Color changes and acetaldehyde release from CDMOF-b did not support any chemical
reaction, throughout the inclusion time and release. Thus, CDMOFb may be suitable to build inclusion complexes for various organic
compounds.

4. Conclusions
In this study, two different types of stable, accessible, high
surface area and microporous sugar moiety based MOF structures
with high density of reactive and accessible hydroxyl groups were
synthesized. These MOF structures, CDMOF-a and CDMOF-b, were
evaluated for the encapsulation of acetaldehyde and its release
kinetics using GC and TGA. It was observed that CDMOF-b can
successfully host and release acetaldehyde molecules into its
pores. However, aldol condensation reaction was observed during
encapsulation of acetaldehyde in CDMOF-a molecules, which induced color changes in CDMOF-a crystals from colorless to red
color powder due to the formation of resinous material.
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